1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cerebral Angiography Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cerebral Angiography Market, by Product Type
8.1.1. Cerebral Angiography Systems
8.1.1.1. Market Revenue and Forecast
8.1.2. Angiography Catheters
8.1.2.1. Market Revenue and Forecast
8.1.3. Guidewires
8.1.3.1. Market Revenue and Forecast
8.1.4. Contrast Media
8.1.4.1. Market Revenue and Forecast
9.1. Cerebral Angiography Market, by Technology
9.1.1. Digital Subtraction Angiography (DSA)
9.1.1.1. Market Revenue and Forecast
9.1.2. Computed Tomography Angiography (CTA)
9.1.2.1. Market Revenue and Forecast
9.1.3. Magnetic Resonance Angiography (MRA)
9.1.3.1. Market Revenue and Forecast
10.1. Cerebral Angiography Market, by Procedure Type
10.1.1. Diagnostic Cerebral Angiography
10.1.1.1. Market Revenue and Forecast
10.1.2. Interventional Cerebral Angiography
10.1.2.1. Market Revenue and Forecast
11.1. Cerebral Angiography Market, by End User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Diagnostic Imaging Centers
11.1.2.1. Market Revenue and Forecast
11.1.3. Specialty Neurology Clinics
11.1.3.1. Market Revenue and Forecast
12.1. Cerebral Angiography Market, by Indication
12.1.1. Stroke
12.1.1.1. Market Revenue and Forecast
12.1.2. Aneurysm
12.1.2.1. Market Revenue and Forecast
12.1.3. Arteriovenous Malformation (AVM)
12.1.3.1. Market Revenue and Forecast
12.1.4. Carotid Artery Disease
12.1.4.1. Market Revenue and Forecast
12.1.5. Brain Tumors
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type
13.1.2. Market Revenue and Forecast, by Technology
13.1.3. Market Revenue and Forecast, by Procedure Type
13.1.4. Market Revenue and Forecast, by End User
13.1.5. Market Revenue and Forecast, by Indication
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type
13.1.6.2. Market Revenue and Forecast, by Technology
13.1.6.3. Market Revenue and Forecast, by Procedure Type
13.1.6.4. Market Revenue and Forecast, by End User
13.1.6.5. Market Revenue and Forecast, by Indication
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type
13.1.7.2. Market Revenue and Forecast, by Technology
13.1.7.3. Market Revenue and Forecast, by Procedure Type
13.1.7.4. Market Revenue and Forecast, by End User
13.1.7.5. Market Revenue and Forecast, by Indication
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type
13.2.2. Market Revenue and Forecast, by Technology
13.2.3. Market Revenue and Forecast, by Procedure Type
13.2.4. Market Revenue and Forecast, by End User
13.2.5. Market Revenue and Forecast, by Indication
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type
13.2.6.2. Market Revenue and Forecast, by Technology
13.2.6.3. Market Revenue and Forecast, by Procedure Type
13.2.7. Market Revenue and Forecast, by End User
13.2.8. Market Revenue and Forecast, by Indication
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type
13.2.9.2. Market Revenue and Forecast, by Technology
13.2.9.3. Market Revenue and Forecast, by Procedure Type
13.2.10. Market Revenue and Forecast, by End User
13.2.11. Market Revenue and Forecast, by Indication
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type
13.2.12.2. Market Revenue and Forecast, by Technology
13.2.12.3. Market Revenue and Forecast, by Procedure Type
13.2.12.4. Market Revenue and Forecast, by End User
13.2.13. Market Revenue and Forecast, by Indication
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type
13.2.14.2. Market Revenue and Forecast, by Technology
13.2.14.3. Market Revenue and Forecast, by Procedure Type
13.2.14.4. Market Revenue and Forecast, by End User
13.2.15. Market Revenue and Forecast, by Indication
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type
13.3.2. Market Revenue and Forecast, by Technology
13.3.3. Market Revenue and Forecast, by Procedure Type
13.3.4. Market Revenue and Forecast, by End User
13.3.5. Market Revenue and Forecast, by Indication
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type
13.3.6.2. Market Revenue and Forecast, by Technology
13.3.6.3. Market Revenue and Forecast, by Procedure Type
13.3.6.4. Market Revenue and Forecast, by End User
13.3.7. Market Revenue and Forecast, by Indication
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type
13.3.8.2. Market Revenue and Forecast, by Technology
13.3.8.3. Market Revenue and Forecast, by Procedure Type
13.3.8.4. Market Revenue and Forecast, by End User
13.3.9. Market Revenue and Forecast, by Indication
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type
13.3.10.2. Market Revenue and Forecast, by Technology
13.3.10.3. Market Revenue and Forecast, by Procedure Type
13.3.10.4. Market Revenue and Forecast, by End User
13.3.10.5. Market Revenue and Forecast, by Indication
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type
13.3.11.2. Market Revenue and Forecast, by Technology
13.3.11.3. Market Revenue and Forecast, by Procedure Type
13.3.11.4. Market Revenue and Forecast, by End User
13.3.11.5. Market Revenue and Forecast, by Indication
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type
13.4.2. Market Revenue and Forecast, by Technology
13.4.3. Market Revenue and Forecast, by Procedure Type
13.4.4. Market Revenue and Forecast, by End User
13.4.5. Market Revenue and Forecast, by Indication
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type
13.4.6.2. Market Revenue and Forecast, by Technology
13.4.6.3. Market Revenue and Forecast, by Procedure Type
13.4.6.4. Market Revenue and Forecast, by End User
13.4.7. Market Revenue and Forecast, by Indication
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type
13.4.8.2. Market Revenue and Forecast, by Technology
13.4.8.3. Market Revenue and Forecast, by Procedure Type
13.4.8.4. Market Revenue and Forecast, by End User
13.4.9. Market Revenue and Forecast, by Indication
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type
13.4.10.2. Market Revenue and Forecast, by Technology
13.4.10.3. Market Revenue and Forecast, by Procedure Type
13.4.10.4. Market Revenue and Forecast, by End User
13.4.10.5. Market Revenue and Forecast, by Indication
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type
13.4.11.2. Market Revenue and Forecast, by Technology
13.4.11.3. Market Revenue and Forecast, by Procedure Type
13.4.11.4. Market Revenue and Forecast, by End User
13.4.11.5. Market Revenue and Forecast, by Indication
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type
13.5.2. Market Revenue and Forecast, by Technology
13.5.3. Market Revenue and Forecast, by Procedure Type
13.5.4. Market Revenue and Forecast, by End User
13.5.5. Market Revenue and Forecast, by Indication
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type
13.5.6.2. Market Revenue and Forecast, by Technology
13.5.6.3. Market Revenue and Forecast, by Procedure Type
13.5.6.4. Market Revenue and Forecast, by End User
13.5.7. Market Revenue and Forecast, by Indication
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type
13.5.8.2. Market Revenue and Forecast, by Technology
13.5.8.3. Market Revenue and Forecast, by Procedure Type
13.5.8.4. Market Revenue and Forecast, by End User
13.5.8.5. Market Revenue and Forecast, by Indication
14.1. Braun Melsungen AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. AngioDynamics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Medtronic
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Shimadzu Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Cardinal Health.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Boston Scientific Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Canon Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Siemens Healthcare GmbH
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Koninklijke Philips N.V.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. General Electric Company
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
